Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment
NCT05334290
·
clinicaltrials.gov ↗
UNKNOWN
Status
400
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Sponsor
Massimo Falconi